KI-Beratung Beta

Gutscheinbedingungen

**Gültig bis 18.11.2026 auf englischsprachige Klassiker (klassiker-32728) online auf thalia.at und in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Ausgenommen sind preisgebundene Artikel & eBooks. Pro Einkauf einmal einlösbar. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Geschenkkarten, Versandkosten und Services.

  • Produktbild: Frontiers of Biostatistical Methods and Applications in Clinical Oncology
  • Produktbild: Frontiers of Biostatistical Methods and Applications in Clinical Oncology
- 11%

Frontiers of Biostatistical Methods and Applications in Clinical Oncology

11% sparen

106,99 € UVP 120,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

This book presents the state of the art of biostatistical methods and their applications in clinical oncology. Many methodologies established today in biostatistics have been brought about through its applications to the design and analysis of oncology clinical studies. This field of oncology, now in...

Beschreibung

This book presents the state of the art of biostatistical methods and their applications in clinical oncology. Many methodologies established today in biostatistics have been brought about through its applications to the design and analysis of oncology clinical studies. This field of oncology, now in the midst of evolution owing to rapid advances in biotechnologies and cancer genomics, is becoming one of the most promising disease fields in the shift toward personalized medicine. Modern developments of diagnosis and therapeutics of cancer have also been continuously fueled by recent progress in establishing the infrastructure for conducting more complex, large-scale clinical trials and observational studies. The field of cancer clinical studies therefore will continue to provide many new statistical challenges that warrant further progress in the methodology and practice of biostatistics. This book provides a systematic coverage of various stages of cancer clinical studies. Topics from modern cancer clinical trials include phase I clinical trials for combination therapies, exploratory phase II trials with multiple endpoints/treatments, and confirmative biomarker-based phase III trials with interim monitoring and adaptation. It also covers important areas of cancer screening, prognostic analysis, and the analysis of large-scale molecular data in the era of big data.

Rezension

“I strongly recommend that those statisticians working in the clinical oncology field check out these articles. Several were of use to me and I know that others will find them to be of use as well.” (David E. Booth, Technometrics, Vol. 60 (3), 2018)

Portrait

Shigeyuki Matsui, Professor, Department of Biostatistics, Nagoya University Graduate School of Medicine, smatsui@med.nagoya-u.ac.jp, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan
John Crowley, President and CEO, Cancer Research and Biostatistics, johnc@crab.org, 1730 Minor Ave STE 1900  Seattle, WA 98101-1468

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

17.10.2017

Abbildungen

XIII, 438 p. 89 illus.

Herausgeber Shigeyuki Matsui + weitere

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

17.10.2017

Abbildungen

XIII, 438 p. 89 illus.

Herausgeber
Verlag Springer Singapore
Seitenzahl

438

Maße (L/B/H)

24,1/16/3 cm

Gewicht

788 g

Auflage

1st ed. 2017

Sprache

Englisch

ISBN

978-981-10-0124-6

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Frontiers of Biostatistical Methods and Applications in Clinical Oncology
  • Produktbild: Frontiers of Biostatistical Methods and Applications in Clinical Oncology
  • 1. Phase I clinical trials.- 2. Phase II clinical trials.- 3. Phase III clinical trials.- 4. Evaluation of surrogate endpoints.- 5. Disease Screening/development of diagnosis.- 6. Analysis of omics data (genomic signature developments etc).- 7. Causal inference in clinical trials and observational studies.